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Background: On 20 February 2020, a locally acquired 
coronavirus disease (COVID-19) case was detected in 
Lombardy, Italy. This was the first signal of ongoing 
transmission of severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) in the country. The num-
ber of cases in Italy increased rapidly and the country 
became the first in Europe to experience a SARS-CoV-2 
outbreak. Aim: Our aim was to describe the epidemi-
ology and transmission dynamics of the first COVID-
19 cases in Italy amid ongoing control measures.
Methods: We analysed all RT-PCR-confirmed COVID-19 
cases reported to the national integrated surveillance 
system until 31 March 2020. We provide a descrip-
tive epidemiological summary and estimate the basic 
and net reproductive numbers by region. Results: Of 
the 98,716 cases of COVID-19 analysed, 9,512 were 
healthcare workers. Of the 10,943 reported COVID-
19-associated deaths (crude case fatality ratio: 11.1%) 
49.5% occurred in cases older than 80 years. Male 
sex and age were independent risk factors for COVID-
19 death. Estimates of R0  varied between 2.50 (95% 
confidence interval (CI): 2.18–2.83) in Tuscany and 
3.00 (95% CI: 2.68–3.33) in Lazio. The net reproduc-
tion number Rt in northern regions started decreasing 
immediately after the first detection.
Conclusion: The COVID-19 outbreak in Italy showed a 
clustering onset similar to the one in Wuhan, China. 
R0 at 2.96 in Lombardy combined with delayed detec-
tion explains the high case load and rapid geographi-
cal spread. Overall, Rt  in Italian regions showed early 
signs of decrease, with large diversity in incidence, 
supporting the importance of combined non-pharma-
cological control measures.
Introduction
Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) infection in humans causing clusters of 
severe pneumonia [1-3] was first detected in the city 
of Wuhan, China, in December 2019 and designated 
as SARS-CoV-2 based on phylogeny, taxonomy and 
established practice [4]. Although of probable zoonotic 
origin, human-to-human transmission rapidly fuelled 
the spread of SARS-CoV-2 infections globally; the main 
known route of transmission is through respiratory 
droplets, however air-borne transmission has been 
acknowledged in specific settings (e.g. aerosol-gen-
erating medical procedures) [5]. Transmission through 
contact with contaminated objects/surfaces (fomite 
transmission) is considered possible.
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Cases in Europe were initially limited to small travel-
related clusters in Germany [6], France [6,7] and the 
United Kingdom [8]. On 20 February 2020, the first 
case of locally acquired SARS-CoV-2 infection was 
diagnosed in northern Italy in a critically ill, hospital-
ised young man with no travel history to known areas 
of viral circulation or link to a probable or confirmed 
case of coronavirus disease (COVID-19). Before this 
date, only three cases of COVID-19 had been reported 
in central Italy, all with a travel history to Wuhan [9].
Following this unexpected finding, extensive contact 
tracing and testing of close contacts revealed ongoing 
transmission in several municipalities of the Lombardy 
region [10,11]. In subsequent days and weeks, case 
counts and death tolls increased rapidly, at first in 
northern Italy and then in the rest of the country. The 
Italian government imposed increasingly strict physi-
cal distancing measures starting with the closure of 10 
municipalities in the Lodi province (Lombardy) and one 
in the Padua province (Veneto) on 23 February 2020. 
This culminated in a national lockdown on 11 March 
2020 [12,13].
Figure 1
Epidemiological curves of COVID-19 cases by date of onset and date of diagnosis/sample, Italy, 28 January–31 March 2020 
(n = 98,716)
Undetected local COVID-19 circulation Known local COVID-19 circulation
22 Jan: Surveillance of COVID-19 among severe cases of acute respiratory infectionwith epidemiological links
            Laboratory network with confirmation capacity set up
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COVID-19: coronavirus disease; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
In total 819 cases reported onset of symptoms before 20 February.
Completeness of information by date is not 100%. In total, 2,200 cases reported in the study period are not included in the graph as both 
dates of symptom onset and date of sample/diagnosis were missing.
Source: Italian National Integrated Surveillance for COVID-19 (updated on 31 March 2020).
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Figure 2
COVID-19 attack rates per 100,000 population (age-adjusted) by region/AP of diagnosis (A) and number of cases by region/
AP of diagnosis (n = 98,716) (B) and by municipality of residence when in the region of diagnosis (n = 93,885) (C), Italy, 28 
January–31 March 2020
AP: autonomous provinces; COVID-19: coronavirus disease.
Source: Italian National Integrated Surveillance for COVID−19 (updated on 31 March 2020).
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The aim of this study was to describe the epidemiology 
and transmission dynamics of the first COVID-19 cases 
in Italy in the context of the progressive implementa-
tion of control measures culminating in a national lock-
down. We summarise the key epidemiological findings 
from the first 98,716 confirmed COVID-19 cases in Italy, 
including 10,943 associated deaths, assess risk fac-
tors independently associated with death and analyse 
basic and net reproductive numbers by symptom onset 
across different regions to explore early SARS-CoV-2 
transmission trends.
Methods
A case-based surveillance system for all laboratory-
confirmed human SARS-CoV-2 infections, following the 
case definition from the European Centre for Disease 
Prevention and Control (ECDC) [14], was established on 
27 February 2020. Before that date, surveillance had 
focused, also in line with European Union (EU) recom-
mendations, on suspected and confirmed COVID-19 
severe respiratory disease [9]. Data were collected 
daily from the 21 Italian regions and autonomous prov-
inces (AP), using a secure online platform. In the early 
phases of the outbreak, if uploading to the secure 
platform was not possible, regions and AP sent data-
sets daily via email. The following information was col-
lected: demographics, clinical severity, comorbidities, 
date of symptom onset, date of diagnosis, outcome, 
region of diagnosis and province of residence. Data on 
the three imported cases that were notified before 20 
February were integrated in the new database.
Laboratory confirmation by RT-PCR was performed on 
nasopharyngeal swabs as previously described [11,15]. 
From the beginning of the outbreak until 1 March 2020, 
all initially confirmed cases were sent to the National 
Reference Laboratory in the Istituto Superiore di Sanità 
(ISS) and re-confirmed using RT-PCR protocols that 
were based on the methods described by Corman et al. 
[16] and the United States Centers for Disease Control 
and Prevention (US CDC) [17]. Concordance among con-
firmation results of 99% demonstrated confirmation 
capacity of the regional laboratory network. As a con-
sequence, after 1 March, all COVID-19 cases were con-
firmed directly by regional reference laboratories [18].
Every day, the data were harmonised in a single data-
set, cleaned and analysed to produce the main surveil-
lance outputs (infographics and detailed bulletins). 
These outputs are publicly available on the ISS epide-
miology web portal (EpiCentro) [19].
We extracted consolidated data from the integrated 
surveillance system on 31 March 2020 and integrated 
imported cases confirmed before 27 February and noti-
fied to the previous surveillance system.
We summarised the data by age group and sex and 
counted cases by date of diagnosis/sample and of 
symptom onset. We aggregated cases by region/AP of 
diagnosis and by municipality of residence for cases 
residing in the same region/AP of diagnosis. Attack 
rates per 100,000 population by region/AP were cal-
culated using population estimates for 2019, available 
from the Italian National Institute of Statistics (Istituto 
Nazionale di Statistica; ISTAT) and adjusted using the 
age distribution of the Italian population as a refer-
ence. We classified the attack rates in each region as 
high, intermediate and low based on the interquartile 
range (IQR) of the adjusted attack rates as follows: (i) 
high: attack rates higher than the upper limit of the 
IQR, (ii) intermediate: within the IQR, (iii) low: lower 
than the lower limit of the IQR.
Case fatality ratios (CFR) were calculated by age and 
sex and smoothed with the locally weighted regression 
Table 1
Adjusted odds ratios of death in COVID-19 cases reported to national surveillance, Italy, 28 January–31 March 2020 
(n = 97,942)
Crude OR 95% CI p value AOR 95% CI p value
Age (years)
< 40 1.00 Reference 1.00 Reference
40–49 3.16 2.05–4.85 < 0.001 3.27 2.12–5.02 < 0.001
50–59 9.02 6.11–13.33 < 0.001 8.49 5.74–12.55 < 0.001
60–69 33.16 22.63–48.59 < 0.001 26.29 17.93–38.56 < 0.001
70–79 103.62 70.89–151.44 < 0.001 80.75 55.20–118.13 < 0.001
80–89 173.32 118.59–253.30 < 0.001 158.00 107.99–231.17 < 0.001
≥ 90 174.27 118.61–256.04 < 0.001 202.29 137.42–297.78 < 0.001
Sex Male vs female 1.85 1.77–1.93 < 0.001 1.85 1.76–1.94 < 0.001
Healthcare worker Yes vs no/not indicated 0.02 0.01–0.03 < 0.001 0.12 0.08–0.17 < 0.001
Calendar week period of diagnosis 
(as described in the Methods)
Per 1 week 
increase 0.64 0.63–0.65 < 0.001 0.59 0.57–0.60 < 0.001
AOR: adjusted odds ratio; CI: confidence interval; OR: odds ratio.
This analysis includes 97,942 of 98,716 (99.2%) cases. The remaining 774 cases were excluded because data on age, sex and/or calendar 
week were missing. AOR were calculated from a multilevel logistic model clustered on reporting regions/autonomous provinces.
Source: Italian National Integrated Surveillance for COVID−19 (extracted on 31 March 2020).
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method. Data were analysed as per the latest available 
data extracted, not adjusting for the reporting delay 
that is expected to affect more recent data. As the epi-
demic was still evolving at the time this analysis was 
performed, we decided to perform minimum group-
level adjustments. The crude odds ratios (OR) of death 
by age were also calculated by calendar period of diag-
nosis/sample by identifying the following calendar 
week periods: before 4 March (when data was sparse), 
4–10, 11–17, 18–24 and 25–31 March. We also assessed 
the OR of death among HCW. A multilevel (clustered by 
region/AP) multivariable logistic model was applied to 
evaluate characteristics associated with death, includ-
ing age group (i.e. < 40, 40–49, 50–59, 60–69, 70–79, 
80–89, ≥ 90 years), sex, HCW status and week of diag-
nosis/sample. Crude and adjusted odds ratios were 
estimated.
The analyses were performed using STATA (version 16) 
and R (version 3.6.3). The list of the R packages used 
for the analysis is available in the Supplement.
Definitions
Clinical severity for people with laboratory-confirmed 
SARS-CoV-2 infection was defined as follows: (i) 
asymptomatic: no apparent signs or symptoms of dis-
ease, (ii) paucisymptomatic: general mild symptoms 
(e.g. general malaise, low grade fever, tiredness) but 
no clear signs of disease, (iii) mild: clear signs and 
symptoms of disease (e.g. symptoms of respiratory dis-
ease described in the case definition as dry cough and 
shortness of breath) but not severe enough to require 
hospitalisation, (iv) severe: clear signs and symptoms 
of disease (e.g. respiratory disease) and severe enough 
to require hospitalisation, and (v) critical: clear signs 
and symptoms of disease (e.g. respiratory disease) 
and severe enough to require admission to an intensive 
care unit (ICU).
The surveillance system captures whether the reported 
subject is a healthcare worker (HCW). We defined a 
HCW broadly as a person who has ever worked in the 
healthcare sector regardless of role, profession or cur-
rent working status. The system also records whether 
the affected person has one of the following comorbid-
ities: cardio-vascular diseases, respiratory diseases, 
diabetes, immunodeficiencies, metabolic diseases, 
oncological diseases, obesity, kidney diseases or other 
chronic diseases.
We defined a COVID-19-associated death as any per-
son with a laboratory-confirmed SARS-CoV-2 infection 
who has died, regardless of where the death occurred 
(hospital, home, other). This definition did not include 
a temporal or causal component.
Transmission dynamics
The basic reproduction number R0  is defined as the 
average number of secondary cases generated in a 
fully susceptible population by a primary infector. This 
is an expression of the potential for transmission in the 
absence of any containment measure. However, once 
interventions are introduced or the susceptibility in 
the population decreases, the transmission potential 
at a given time t is measured as the net reproduction 
number  Rt  . In this paper, we estimated both R0  and 
Rt  for Italian regions in different epidemiological 
situations (high and intermediate age-adjusted attack 
rates), selected among those with highest data robust-
ness. We used a previously described Bayesian 
approach [20-22], informed by estimates of the serial 
interval distribution (average: 6.6 days) from contact 
tracing data in Lombardy [11]. Details are reported in 
the  Supplement. Modelling was based on data avail-
able by 31 March 2020.
Ethical statement
This study was conducted using data from the Italian 
national integrated COVID-19 surveillance routinely col-
lected and analysed within the mandate of the Italian 
National Institute of Health; therefore, no ethical 
approval was necessary.
Results
From 28 January (when the first imported case was 
detected) to 31 March 2020 (date of data extraction), 
98,716 confirmed cases of COVID-19 were reported 
including 10,943 related deaths. After a rapid increase, 
the number of reported cases began to stabilise and 
decrease (Figure 1). Locally acquired cases diagnosed 
from the end of February reported onset of symptoms 
from 28 January onwards (819 cases with symptom 
onset before 20 February), indicating undetected local 
transmission for at least 3 weeks before detection. The 
average delay between symptom onset and diagnosis/
Figure 3
COVID-19 case fatality ratio by age at diagnosis and sex, 

















Dots: single years of age; lines: locally weighted regression curves 
showing the estimated trend; grey shaded area: band width 
represents the 95% confidence intervals.
Source: Italian National Integrated Surveillance for COVID−19 
(updated on 31 March 2020). Three deaths among cases with 
missing age are not included.
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sample in the first month of the outbreak was 5.6 days 
(median: 5 days, IQR: 2–8 days). 
Specific control measures were applied nationwide 
from 4 March. Before that date, distancing measures 
were in place only in areas of Lombardy and Veneto. 
On 4 March, the first government decree on a national 
scale was issued. This introduced measures including 
suspension of congresses and large meetings, shows 
(live and cinema), sports events/trainings with audi-
ence and any other events that could lead to mass gath-
erings, closure of all schools and suspension of school 
trips, visiting restrictions in hospitals and long-term 
care facilities. It promoted information sharing and 
increased hygiene measures (e.g. on public transports) 
allowing other activities to continue provided distanc-
ing could be guaranteed. It opened to the possibility of 
applying agile working/home working where possible 
through a simplified administrative procedure without 
imposing it and invited more fragile population groups 
(e.g. elderly and immunocompromised people) to stay 
at home as much as possible or at least try to avoid 
gatherings. On 11 March, another government decree 
was issued that first imposed more strict physical 
distancing measures (labelled diffusely as ‘lockdown 
measures’ in the country) including the suspension of 
all commercial activities except for those selling pri-
mary goods including groceries and drugs. It further 
imposed the closure of restaurants/bars (allowing 
some exceptions such as take-away and home deliv-
ery) and of services such as hairdressers and beauty 
salons. It also identified core services and activities 
that should not be suspended but should apply strict 
security protocols on site and use home working to the 
maximum extent, also incentivising the use of leaves 
and furlough schemes. Movement limitation for pro-
ductive activities was also introduced at this stage, 
with subsequent decrees expanded to include all 
movements within the country, ultimately leading to a 
general stay-at-home recommendation.
By 31 March, 2020, all of Italy’s 21 regions and AP 
had reported at least one locally acquired case of 
COVID-19. The country had high incidence areas with 
sustained local transmission (mainly in the north), 
low incidence areas with limited but growing num-
bers of locally acquired cases of infection and regions 
with intermediate incidence (Figure 2). Overall, 98% 
(42,279/43,206) of COVID-19 cases diagnosed in 
Lombardy were among people residing in this region. 
Among the remaining 2% of cases for whom the place 
of residence was known, most (123 cases) reported 
being residents in the neighbouring region of Emilia-
Romagna. The index case of the outbreak was not 
found, and no clear chains of transmission were identi-
fied linking initial cases in newly affected regions/AP.
Age-adjusted attack rates per 100,000 were classified 
as high in Lombardy (crude attack rate: 429.3; age-
adjusted attack rate: 431.6/100,000), in the autono-
mous province of Trento, in Aosta Valley, in the region 
of Emilia-Romagna and in the autonomous province 
of Bolzano. Age-adjusted attack rates were classified 
as intermediate in Marche, Veneto, Piedmont, Liguria, 
Friuli-Venezia Giulia, Abruzzo, Tuscany, Umbria, Lazio 
and Apulia. In Molise, Sardinia, Calabria, Campania, 
Sicily and Basilicata, age-adjusted attack rates were 
classified as low (Figure 2 and Table 1, Supplementary 
Table S1).
Most affected cases were male (55.4%) and the median 
age of cases was 62 years. Notably, 9,512 cases were 
reported among HCW (median age: 49 years; IQR: 
40–59; 33.6% male).
Among 98,503 cases with known age, clinical sever-
ity was reported for 35,692 cases. Additional infor-
mation from sensitivity analyses can be found in 
the  Supplement. In particular,  Supplementary Figure 
2A shows that the proportion of severe cases younger 
than 7 years was below 15%. This proportion decreased 
to 4.9% in the age group 7–19 years. In older age 
groups, the proportion increased gradually to 33.1% 
in the age group 80–89 years. Critical severity was 
reported in cases 20 years and older, reaching 5.5% 
in the 60–69 year age segment (Supplementary Table 
S2).
Among all cases, 54,808 (55.5%) were reported to 
have been managed in their place of residence and 
16,625 (16.8%) were hospitalised. For 27,283 (27.6%) 
cases, this information was not available. As shown 
in  Supplementary Figure 2B, the proportion of hos-
pitalised COVID-19 cases decreased from the 0–1 to 
Table 2
Estimated epidemic doubling time and R0 in selected regions, Italy, 28 January–31 March 2020 (n = 43,625 cases with a date 
of symptom onset)
Region Adjusted AR classification Doubling time (days) 95% CI R₀ 95% CI
Lombardy High 2.7 2.2–3.5 2.96 2.73–3.17
Veneto Intermediate 3.2 2.5–4.2 2.51 2.18–2.86
Emilia-Romagna High 2.7 2.3–3.3 2.84 2.57–3.13
Tuscany Intermediate 3.2 2.3–5.2 2.50 2.18–2.83
Lazio Intermediate 2.9 2.2–4.3 3.00 2.68–3.33
Apulia Intermediate 2.9 2.2–4.3 2.61 2.13–3.13
AR: attack rate; CI: confidence interval; R₀: basic reproduction number.
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the 7–19 year age group and increased progressively 
from the 20–29 to the 70–79 year age group when it 
appeared to stabilise. Supplementary Figure 2C shows 
for all reported hospitalised COVID-19 cases with known 
unit of admission and age (n = 13,390) the proportion 
of patients admitted to ICU vs those admitted to any 
other hospital unit. Overall, the ICU admission rate 
was 19.2% considering as denominator only cases 
for whom admission hospital unit was reported. This 
decreased to 15.5% when all cases reported to have 
been hospitalised were included in the denominator. 
There were ICU admissions from the age group 2–6 
years onwards, increasing in proportion until age group 
60–69 years. The proportion decreased in older age 
groups.
Of the 10,943 reported COVID-19 associated deaths, 
49.5% occurred in cases 80 years or older with an 
overall crude CFR of 11.1% (the detailed distribution 
of COVID-19 cases and related deaths reported until 
31 March 2020, by age decade and sex are available 
in  Supplementary Table S3). Overall, 21 deaths were 
reported in HCW (CFR: 0.2%).
Until 31 March 2020, no deaths had been reported 
among cases younger than 30 years. Overall, 
65.6% of the people who died had at least one 
Figure 4
COVID-19 estimated Rt in selected Italian regions over a 7-day moving average, Italy, January 28–March 12, 2020
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co-morbidity.  Figure 3  shows the CFR reported by 31 
March 2020 by single year of age of diagnosed cases 
stratified by sex smoothed using locally weighted 
regression curves. There was a sharp increase of the 
CFR with age in both sexes, however, women had a 
lower CFR at each age point.
When stratifying by age group and calendar period 
of diagnosis/sample, we confirmed the age effect on 
the CFR. Moreover, the CFR calculated for cases diag-
nosed in the earlier phase of the epidemic and thus 
with a long follow-up at the time of data extraction was 
higher, with an overall CFR of 21.9% for people diag-
nosed with COVID-19 before 4 March (Supplementary 
Table S4).
After adjusting for age, sex, HCW profession and cal-
endar period of diagnosis/sample, we estimated higher 
adjusted odds ratios (AOR) of death with increasing 
age decade and a higher AOR for male compared with 
female cases. The HCW diagnosed with COVID-19 had 
lower AOR of death than the non-HCW (Table 1). No 
evidence of improved fit (p = 0.09, log-likelihood ratio 
test) was found when testing for possible interaction 
between sex and age group. We saw similar results 
when restricting the analysis to 20–70 year-old cases 
and when excluding from the analysis cases with 
uncertain HCW status (data not shown). In this further 
analysis we also evaluated the interaction between age 
and sex with HCW but again there was not a significant 
better fit (p = 0.52 for age, p = 0.24 for sex by log-likeli-
hood ratio test).
We estimated the transmission patterns for six Italian 
regions (Lombardy, Veneto, Emilia-Romagna, Tuscany, 
Lazio and Apulia) with adjusted AR classification 
ranging from intermediate to high. These six regions 
were characterised by different epidemic trajectories. 
Although with overlapping confidence intervals (CI), 
variability was also clearly visible in terms of epidemic 
doubling time, which varied between 2.7 days (95% 
CI: 2.3–3.3) in Emilia-Romagna and 3.2 days (95% CI: 
2.5–4.2) in Veneto (Table 2), and basic reproductive 
numbers, which were in the range 2.13–3.33.
In Lombardy, we estimated that the net reproduction 
number Rt had been above the epidemic threshold since 
late January 2020 (Figure 4). In February, the Rt started 
to fluctuate, reaching maximum values around 3 in the 
week from 17 to 23 February. Starting from 24 February, 
with the enforcement of a quarantined area around the 
most affected municipalities of the region, Rt estimates 
followed a constantly decreasing trend. The second 
and third most affected regions in February (Veneto 
and Emilia-Romagna) showed an increasing trend of 
Rt until about 24 February (Figure 4). At that time, a few 
tens of cases had been detected in those regions. 
The transmission patterns of Tuscany, Lazio and Apulia 
were markedly different. In central and southern Italy 
where these regions are located, the epidemic spread 
was largely undetected until early March. After an ini-
tial increase, Rt  remained nearly constant at values 
around 2.5–3 until 4–8 March when physical distancing 
measures were implemented at national level (Figure 
4).
Discussion
The early epidemiology of COVID-19 in Italy was het-
erogeneous, with a north-to-south incidence gradient 
and very different transmission dynamics. However, 
across all studies regions, transmission consistently 
decreased following disease detection and implemen-
tation of combined non-pharmacological measures. 
Most of the cases detected in the first month of the 
outbreak were male with a median age of 62 years. The 
median age was very high, considering the subsequent 
evolution of the epidemic [19] in Italy. This influenced 
the disease outcomes we observed, as the proportion 
of severe cases increased with age, as did the hospital-
isation rate. We also found older age and male sex to 
be independent risk factors for death associated with 
COVID-19.
COVID-19 emerged in Italy with a similar clustering 
onset as described in Wuhan, China [2], with three 
major clusters around the cities of Codogno, Bergamo 
and Cremona in the Lombardy region in northern Italy 
[11]. Subsequently, cases spread across the country 
with more sustained transmission in neighbouring 
regions in the north and in the central region of Marche. 
Our quantification of the transmission dynamics of 
the first COVID-19 cases in Italy confirm this observa-
tion, with a heterogeneous estimate for the epidemic 
doubling times and basic reproductive numbers. We 
also observed varying timing and magnitude of the 
net reproduction numbers across regions with earlier 
increases in Lombardy and Veneto and a later onset in 
central and southern Italy.
The epidemic curve suggests that the earliest cases 
were detected with a considerable delay (up to 3 
weeks), suggesting that the detection of local trans-
mission of SARS-CoV-2 occurred in a context of ongo-
ing transmission. This was later corroborated by 
environmental studies that highlighted viral circulation 
in northern Italy at the end of 2019 [23]. The high R0, 
the short serial interval and delayed detection amid 
ongoing transmission, explain the rapid case increase 
and geographical spread of the disease in Italy. They 
also explain the inability to identify the index case and 
clearly trace the initial spread of infection across the 
country.
In all regions, we consistently observed a rapid reduc-
tion of the Rt  after the implementation of control 
measures. Notably, in northern regions (Lombardy, 
Veneto and Emilia-Romagna), this marked decreasing 
trend started immediately after detection of the first 
case in late February and was possibly due to increased 
awareness in the population and to the effect of early 
interventions. After 11 March, lockdown allowed 
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the reproduction number to fall below the epidemic 
threshold and control the first wave of SARS-CoV-2 in 
Italy [24].
HCW were disproportionally affected during the first 
acute phase of the SARS-CoV-2 epidemic in Italy. This 
underlines the fact that SARS-CoV-2 can easily spread 
in healthcare contexts and emphasises the importance 
of strong infection prevention and control practices. 
In Italy, as described in other countries [25], nursing 
homes and long-term care facilities have emerged as 
particularly fragile environments in which infection 
can spread very rapidly with potentially disastrous out-
comes owing to the vulnerability of the hosted popula-
tions [26].
As demonstrated previously in China [27], we showed 
in this study worse outcomes in older male patients 
with comorbidities. Male sex and older age were inde-
pendent risk factors for COVID-19-related death, also 
after adjusting for age, sex, HCW profession and cal-
endar period of diagnosis/sample. HCW diagnosed 
with COVID-19 had lower AOR of death than non-HCW. 
Affected HCW, compared with the affected general pop-
ulation, were on average younger and more frequently 
female. Considering the predominance of female pro-
fessionals of working age in the Italian health sector, 
this is the distribution that would be expected in pro-
fessionally exposed groups. Age and sex only explain 
in part the lower CFR, as the AOR of death was lower 
among HCW also after adjusting for those variables 
and might be related to earlier detection and manage-
ment as well as to a ‘healthy worker effect’ [28].
Data on clinical severity and ICU admission of COVID-
19 cases were consistent with observations on the risk 
of COVID-19-related deaths. The proportion of severe 
and critical cases increased with age until age 80 
years. The slight decrease in the proportion of critical 
and severe cases, and the number of deaths, in the 
higher age groups could be due to the demographic 
structure of the population with a higher female-to-
male ratio among older people [29]. Consistently with 
reported disease severity, the proportion of COVID-19 
related ICU admissions increased until the age group 
60–69 years and decreased in older ages. Although 
rare, some ICU admissions were notified in younger 
age groups, confirming the potential for critical disease 
also among children and young adults.
In absolute terms, a COVID-19 CFR of 11.1% was doc-
umented in the early phase of the outbreak in Italy. 
This is higher than that what was observed in other 
countries at the same time. As recently described, 
this could in part be explained by the demographic 
structure of the Italian population [30]. However, other 
aspects such as Italian testing policies at the time that 
focussed on symptomatic cases, the choice to include 
only laboratory-confirmed cases and to define associ-
ated deaths in a very inclusive manner, may also have 
played a role in making initial case fatality data poorly 
comparable across countries. Also, the overall ICU 
admission rate was much higher than the reported 4% 
in 16 EU countries as published at the time by the ECDC 
[31]. We are unable to speculate whether the reasons 
behind this difference are related to a possible detec-
tion bias towards more severe cases, hospitalisation 
policies and practices, or whether there were other fac-
tors at play.
In particular, higher CFR could also be an expression 
of the impact that an uncontrolled SARS-CoV-2 trans-
mission has on healthcare and public health services, 
causing shortage of hospital beds and delays in the 
diagnosis of new cases. Studies from Lombardy have 
highlighted the potentially catastrophic effects of 
COVID-19 on the healthcare system [10,11] and the data 
presented in this paper show the increasing median 
time between time of symptom onset and time of diag-
nosis during the first month of the pandemic. As capac-
ity to track cases and test increased, the time between 
onset and diagnosis decreased again, however this 
was not evident in this first month.
Our study has limitations: Most of the cases detected 
in the first month of the outbreak were male with a 
median age of 62 years. The sex ratio balanced out and 
median age became lower in subsequent phases of the 
outbreak, with an increased proportion of asympto-
matic and mild cases and lower CFR [19]. Considering 
how older age and male sex were found to be risk 
factors for disease severity and death, this suggests 
that in the early phase of the outbreak, more severe 
cases were more likely to be detected. This could be 
due to a change in the detection policies that led to 
the restriction of testing to only symptomatic cases on 
27 February [32] as well as to the stress on the health-
care system that needed to prioritise the diagnosis and 
management of more severe cases. The testing policy 
was broadened to asymptomatic close contacts and to 
various screening programmes (e.g. ahead of hospital 
admission for other causes) following the period exam-
ined in this study when Italy entered the transition 
phase and a test–track–trace strategy was adopted.
Further, the data collected from the Italian integrated 
COVID-19 surveillance system during the initial phase 
of the emergency presented some shortcomings, 
mainly related to lack of completeness. For this rea-
son, some stratifications and analyses are not shown. 
Specifically, the lack of completeness regarding the 
presence and type of comorbidities did not allow us to 
include this in the multivariable analysis of deaths in 
order to assess, and/or adjust for, this factor. In addi-
tion, not all regions reported the date of sampling at 
the beginning of the outbreak and when missing, we 
used date of diagnosis to construct epidemic curves. 
This has limitations because there is a lag between 
diagnostic sampling and confirmation of laboratory 
results. However, this interval is expected to be limited 
to 2–3 days and not to bias excessively the presenta-
tion of the time distribution of cases, especially when 
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combined with the epidemic curve by date of symptom 
onset. We did not adjust data on hospitalisation and 
ICU admissions as well as CFR for the expected time 
for disease evolution and may therefore have underes-
timated it in the more recent period. Finally, the esti-
mation of R0, Rt  and the doubling time were made in 
regions selected on the basis of the robustness of data 
considering epidemiologically diverse settings.
Another relevant consideration is that the early phase 
of the COVID-19 epidemic in Italy was characterised by 
a large number of cases with a short follow-up time 
since diagnosis. This implies that some of the notified 
cases that would die at a later date would still be alive 
at the time of observation and would therefore not be 
counted in the CFR. As a consequence, overall CFR col-
lected in the acute epidemic phase of potentially lethal 
infectious diseases with relatively long time from onset 
to death might be underestimated. We confirmed that 
this is also the case for COVID-19 by performing an 
analysis by period of diagnosis/sample. We found that 
those diagnosed before 4 March 2020 had an overall 
CFR of around 20%. Subsequent studies with longer 
follow-up clarified this aspect better, including studies 
evaluating overall population excess mortality, which 
are also more comparable across countries [33-35].
Conclusion
Even in the presence of the mentioned limitations, our 
analysis provides an overview of the early epidemiol-
ogy of the COVID-19 outbreak in Italy, showing how 
in the context of evident sub-national differences in 
transmission dynamics, transmission consistently 
decreased following disease detection and implemen-
tation of combined non-pharmacological measures.
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